These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 29129850)

  • 1. Prostaglandin terminal synthases as novel therapeutic targets.
    Hara S
    Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(9):703-723. PubMed ID: 29129850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic-deletion of Cyclooxygenase-2 Downstream Prostacyclin Synthase Suppresses Inflammatory Reactions but Facilitates Carcinogenesis, unlike Deletion of Microsomal Prostaglandin E Synthase-1.
    Sasaki Y; Kamiyama S; Kamiyama A; Matsumoto K; Akatsu M; Nakatani Y; Kuwata H; Ishikawa Y; Ishii T; Yokoyama C; Hara S
    Sci Rep; 2015 Nov; 5():17376. PubMed ID: 26611322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders.
    Koeberle A; Werz O
    Biochem Pharmacol; 2015 Nov; 98(1):1-15. PubMed ID: 26123522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostacyclin Synthase as an Ambivalent Regulator of Inflammatory Reactions.
    Ochiai T; Honsawa T; Sasaki Y; Hara S
    Biol Pharm Bull; 2022; 45(8):979-984. PubMed ID: 35908907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of the Topological Distances and Activities between mPGES-1 and COX-2 versus COX-1: Implications of the Different Post-Translational Endoplasmic Reticulum Organizations of COX-1 and COX-2.
    Akasaka H; So SP; Ruan KH
    Biochemistry; 2015 Jun; 54(23):3707-15. PubMed ID: 25988363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anti-inflammatory and vasoprotective properties of mPGES-1 inhibition offer promising therapeutic potential.
    Steinmetz-Späh J; Jakobsson PJ
    Expert Opin Ther Targets; 2023; 27(11):1115-1123. PubMed ID: 38015194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A profile of NSAID-targeted arachidonic acid metabolisms in human embryonic stem cells (hESCs): implication of the negative effects of NSAIDs on heart tissue regeneration.
    Chillar A; So SP; Ruan CH; Shelat H; Geng YJ; Ruan KH
    Int J Cardiol; 2011 Aug; 150(3):253-9. PubMed ID: 20451268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsomal prostaglandin E2 synthase: a safer target than cyclooxygenases?
    Timmers L; Pasterkamp G; de Kleijn DP
    Mol Interv; 2007 Aug; 7(4):195-9, 180. PubMed ID: 17827439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of microsomal prostaglandin E synthase-1 as targeted therapy in cancer treatment.
    Larsson K; Jakobsson PJ
    Prostaglandins Other Lipid Mediat; 2015 Jul; 120():161-5. PubMed ID: 26100239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of prostacyclin synthase in carcinogenesis.
    Sasaki Y; Ochiai T; Takamura M; Kondo Y; Yokoyama C; Hara S
    Prostaglandins Other Lipid Mediat; 2017 Nov; 133():49-52. PubMed ID: 28506876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of anti-inflammatory drugs targeted against prostaglandin-related molecules].
    Sato T; Nakajima T; Yamano Y
    Nihon Rinsho; 2010 Oct; 68(10):1835-9. PubMed ID: 20954326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of AF3442 [N-(9-ethyl-9H-carbazol-3-yl)-2-(trifluoromethyl)benzamide], a novel inhibitor of human microsomal prostaglandin E synthase-1, on prostanoid biosynthesis in human monocytes in vitro.
    Bruno A; Di Francesco L; Coletta I; Mangano G; Alisi MA; Polenzani L; Milanese C; Anzellotti P; Ricciotti E; Dovizio M; Di Francesco A; Tacconelli S; Capone ML; Patrignani P
    Biochem Pharmacol; 2010 Apr; 79(7):974-81. PubMed ID: 19925781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinction of microsomal prostaglandin E synthase-1 (mPGES-1) inhibition from cyclooxygenase-2 inhibition in cells using a novel, selective mPGES-1 inhibitor.
    Mbalaviele G; Pauley AM; Shaffer AF; Zweifel BS; Mathialagan S; Mnich SJ; Nemirovskiy OV; Carter J; Gierse JK; Wang JL; Vazquez ML; Moore WM; Masferrer JL
    Biochem Pharmacol; 2010 May; 79(10):1445-54. PubMed ID: 20067770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tobacco smoke regulates the expression and activity of microsomal prostaglandin E synthase-1: role of prostacyclin and NADPH-oxidase.
    Barbieri SS; Amadio P; Gianellini S; Zacchi E; Weksler BB; Tremoli E
    FASEB J; 2011 Oct; 25(10):3731-40. PubMed ID: 21737615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsomal prostaglandin E synthase-1 inhibition in cardiovascular inflammatory disease.
    Wang M; Song WL; Cheng Y; Fitzgerald GA
    J Intern Med; 2008 May; 263(5):500-5. PubMed ID: 18410593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation.
    Xu D; Rowland SE; Clark P; Giroux A; Côté B; Guiral S; Salem M; Ducharme Y; Friesen RW; Méthot N; Mancini J; Audoly L; Riendeau D
    J Pharmacol Exp Ther; 2008 Sep; 326(3):754-63. PubMed ID: 18524979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostanoids and inflammatory pain.
    Chen L; Yang G; Grosser T
    Prostaglandins Other Lipid Mediat; 2013; 104-105():58-66. PubMed ID: 22981510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular Biology of Prostanoids and Drug Discovery.
    Zhu L; Zhang Y; Guo Z; Wang M
    Arterioscler Thromb Vasc Biol; 2020 Jun; 40(6):1454-1463. PubMed ID: 32295420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexpression of microsomal prostaglandin E synthase with cyclooxygenase-2 in human rheumatoid synovial cells.
    Kojima F; Naraba H; Sasaki Y; Okamoto R; Koshino T; Kawai S
    J Rheumatol; 2002 Sep; 29(9):1836-42. PubMed ID: 12233875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.